// App-Quantinova.ai

: Maximizing Pre-Transplant Response Is Associated with Improved Outcome for Myeloma Patients: Exploratory Analysis of the Myeloma XI Trial

Researchers

Presenter

  • Charlotte Pawlyn

Principal Investigators

  • David Cairns

  • Alina Striha

  • Anna Hockaday

  • Gwen Jacques

  • John R Jones

  • Kevin Boyd

  • Bhuvan Kishore

  • Mamta Garg

  • Catherine Williams

  • Kamaraj Karunanithi

  • Jindriska Lindsay

  • Matthew Jenner

  • Gordon Cook

  • Nigel H. Russell

  • Martin Kaiser

  • Mark T Drayson

  • Roger G. Owen

  • Walter M Gregory

  • Gareth Morgan

  • Faith E. Davies

Medical Centers

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • Department of Haematology, Northern Institute for Cancer Research, Newcastle upon Tyne, United Kingdom

  • Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

  • Heart of England NHS Foundation Trust, Birmingham, United Kingdom

  • Leicester Royal Infirmary Haematology, Leicester, United Kingdom

  • Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom

  • University Hospital of North Midlands, Stoke-on-Trent, United Kingdom

  • Kent & Canterbury Hospital, Kent, United Kingdom

  • University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

  • Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom

  • University of Birmingham, Birmingham, United Kingdom

  • Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom

  • University of Arkansas for Medical Sciences, Little Rock, AR

  • Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • Thalidomide

  • Bortezomib

  • Vorinostat

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved